Albumin is a protein synthesised in liver, its increase in the Cerebrospinal fluid (CSF) is suggestive of the dysfunction of the blood–brain barrier (BBB) in case of individuals suffering from Alzheimer. Monitoring albumin levels helps healthcare professionals diagnose neurodegenerative disorders and identify the signs of ageing and provide effective therapeutic interventions.